Cell death in retinoblastoma: electron microscopic, immunohistochemical, and DNA fragmentation studies.
Apparent cell loss by apoptosis occurs in carcinomatous tissue. To investigate cell death in retinoblastoma (Rb), ultrastructural examination, ApopTag staining, electrophoresis to detect apoptotic DNA fragmentation, and flow cytometric studies were performed. Immunostaining for the oncogenic products bcl-2 and p53 was also carried out. Relationships between the proliferation fraction (PF), apoptotic index (AI), and the distribution of bcl-2 and p53 were investigated according to the degree of histologic differentiation of Rb. Ultrastructurally, two patterns of cell death were seen. Necrotic cells exhibited vacuolation of cytoplasmic organelles with a marked lytic change in the karyoplasm and cytoplasm. In contrast, apoptotic cells were characterized by crescentic margination of chromatin, condensation of karyoplasm and cytoplasm, and fragmentation of the nucleus. Differentiated Rb had a low AI value (< 1%), whereas undifferentiated Rb had a high AI value (> 8%). The PF of undifferentiated RB (31%) was significantly higher than that of differentiated RB (14%). Analysis of DNA fragmentation using 3'-end labeling with terminal transferase indicated that undifferentiated Rb has increased DNA cleavage. The distribution of apoptotic bodies within Rb was inversely correlated with the expression of bcl-2. A majority of tumor cells of differentiated Rb were negative for p53, whereas 20-40% of tumor cells of undifferentiated Rb showed a positive reaction for p53. These findings suggest that the degree of susceptibility to apoptosis is closely related to PF, is inversely related to the degree of differentiation of Rb, and is protected by oncogene bcl-2.
Cha
S C
SC
Department of Ophthalmology, Youngnam University Medical Center, Taegu, Korea.
Suh
K S
KS
Song
K S
KS
Lim
K
K
D017209:Apoptosis; D002452:Cell Count; D002455:Cell Division; D002467:Cell Nucleus / Q000737:chemistry / Q000648:ultrastructure; D002675:Child, Preschool; D053938:DNA Fragmentation; D004273:DNA, Neoplasm / Q000032:analysis*; D005434:Flow Cytometry; D006801:Humans; D007124:Immunoenzyme Techniques; D007223:Infant; D011003:Ploidies; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000032:analysis; D019572:Retinal Neoplasms / Q000737:chemistry / Q000235:genetics / Q000648:ultrastructure*; D012175:Retinoblastoma / Q000737:chemistry / Q000235:genetics / Q000648:ultrastructure*; D016159:Tumor Suppressor Protein p53 / Q000032:analysis
D004273:DNA, Neoplasm; D019253:Proto-Oncogene Proteins c-bcl-2; D016159:Tumor Suppressor Protein p53